Physician profile
Brian C Fong
NPI 1407888910
$6,751.91
in general payments reported to CMS, 2019-2025
26 companies · $1,254 in 2025
The $1,254 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $134 · 2021: $213 · 2022: $1,607 · 2023: $718 · 2024: $2,216 · 2025: $1,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035 · Travel and Lodging: $1,054 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.58 |
| Travel and Lodging | $1,053.82 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,850.17 | 2020-2025 | Lumenis Pulse 120h, Lithovue, Rezum Generator |
| Olympus Corporation of The Americas | $1,625.97 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $652.72 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $409.41 | 2023-2025 | Erleada |
| Olympus America INC. | $387.86 | 2019-2025 | Itind System, Uretero-Reno Videoscope |
| Procept Biorobotics Corporation | $356.67 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $324.39 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $232.80 | 2024-2025 | |
| Pfizer INC. | $211.30 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $196.32 | 2024-2025 | Prolaris |
| Janssen Scientific Affairs, LLC | $76.93 | 2025 | |
| 180 Medical, INC. | $76.81 | 2024-2025 | Gentlecath Glide |
| Abbvie INC. | $68.25 | 2024-2025 | |
| Accord Healthcare, INC. | $62.54 | 2024-2025 | |
| Endo USA, INC. | $29.36 | 2025 | Xiaflex |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $28.54 | 2024 | Bard Urinary Drainage Bag |
| Ambu INC. | $25.62 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.76 | 2025 | |
| Photocure INC | $20.30 | 2025 | Cysview |
| Blue Earth Diagnostics | $19.83 | 2025 | Posluma |
| Becton, Dickinson and Company | $18.57 | 2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $17.40 | 2025 | |
| Immunitybio, INC. | $15.24 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $11.16 | 2019 | |
| Intuitive Surgical, INC. | $9.17 | 2023 | Da Vinci Surgical System |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.